TCL Archive DCPC Advisors Request New Study Section In Prevention And Control Of Chronic Disease July 30, 1993
TCL Archive House Passes Cancer Act Renewal With Provision Permitting NCI To Reinstate Training Program May 10, 1974
TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease December 28, 2012
